Cargando…
Anticancer Effect of STING Agonist-Encapsulated Liposomes on Breast Cancer
Breast cancer is one of the most common cancers worldwide, posing a serious threat to human health. Recently, innate immunity has become a widely discussed topic in antitumor research. The STING pathway is an important component of innate immunity, and several STING agonists have been developed and...
Autores principales: | Zhang, Jibing, Cui, Xiao, Huang, Yujiao, Xu, Xiangdong, Feng, Changshun, Li, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179927/ https://www.ncbi.nlm.nih.gov/pubmed/37175150 http://dx.doi.org/10.3390/molecules28093740 |
Ejemplares similares
-
Liposome-Based Co-Immunotherapy with TLR Agonist and CD47-SIRPα Checkpoint Blockade for Efficient Treatment of Colon Cancer
por: Chang, Rui, et al.
Publicado: (2023) -
Chemically programmed STING-activating nano-liposomal vesicles improve anticancer immunity
por: Chen, Xiaona, et al.
Publicado: (2023) -
Augmented Anticancer Effects of Cantharidin with Liposomal Encapsulation: In Vitro and In Vivo Evaluation
por: Zhang, Xue, et al.
Publicado: (2017) -
STING Agonists as Cancer Therapeutics
por: Amouzegar, Afsaneh, et al.
Publicado: (2021) -
STING agonist promotes CAR T cell trafficking and persistence in breast cancer
por: Xu, Nuo, et al.
Publicado: (2020)